[PDF] from corimmun.comM Ungerer, K Rosport, A Bültmann, R Piechatzek… - Circulation, 2011 - Am Heart Assoc Methods and Results— In a first-in-humans study, 30 healthy men received a single intravenous administration of 10, 20, 40, 80, or 160 mg Revacept. The serum concentration–time courses of each dosage of Revacept showed a narrow variation and a concentration and time ... Cited by 2 - Related articles - All 6 versions
RL Kronenthal - US Patent 20,110,189,304, 2011 - freepatentsonline.com The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency. The compositions preferably comprise a finely powdered, carboxylic acid salt and a liquid block copolymer of ethylene oxide and propylene oxide. Cached
[HTML] from hematologylibrary.orgJ Ware… - Blood, 2011 - bloodjournal.hematologylibrary.org The late Judah Folkman pioneered the idea that growing solid tumors required active angiogenesis and methods to prevent angiogenesis potentially slowed, or even stopped, tumor growth by starving the tumor. 3 Later, Folkman would implicate the involvement of the circulating blood ... Related articles - All 2 versions
AP Owens… - Circulation research, 2011 - Am Heart Assoc Blood contains microparticles (MPs) derived from a variety of cell types, including platelets, monocytes, and endothelial cells. In addition, tumors release MPs into the circulation. MPs are formed from membrane blebs that are released from the cell surface by proteolytic ... Cited by 3 - Related articles - All 3 versions
[CITATION] V1021 V-LOCK® FOR HEMOSTASIS AND RECONSTRUCTION IN MINIMALLY ACCESS PARTIAL NEPHRECTOMY
V Flamand, R Sanchez-Salas, F Rozet… - The Journal of …, 2011 - Elsevier
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
